Company Filing History:
Years Active: 2009-2012
Title: Tommy Ferm: Innovator in Radiopharmaceuticals
Introduction
Tommy Ferm is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of radiopharmaceuticals, particularly in the development of methods and reagents for carbonylation processes. With a total of 3 patents to his name, Ferm's work is instrumental in advancing medical imaging technologies.
Latest Patents
Ferm's latest patents include innovative methods and reagents for photo-initiated carbonylation using carbon-isotope labeled carbon monoxide with amines and alkyl/aryl iodides. These advancements result in carbon-isotope labeled amides that are particularly useful as radiopharmaceuticals for Positron Emission Tomography (PET). Additionally, he has developed methods and systems for the labeling synthesis of phosgene by UV light. This work facilitates the synthesis of labeled compounds that serve as PET tracers, further enhancing the capabilities of medical imaging.
Career Highlights
Tommy Ferm is currently associated with GE Healthcare Limited, where he continues to push the boundaries of innovation in the healthcare sector. His expertise in radiopharmaceuticals has positioned him as a key player in the development of advanced imaging techniques.
Collaborations
Ferm collaborates with esteemed colleagues such as Tor Kihlberg and Bengt Langström, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Tommy Ferm's contributions to the field of radiopharmaceuticals exemplify the impact of innovative thinking in healthcare. His patents and ongoing work continue to pave the way for advancements in medical imaging technologies.